Why the study?
Does intermittent corticosteroid treatment affect mortality compared to continuous daily treatment in patients with chronic asthma?
Does intermittent corticosteroid treatment affect mortality compared to continuous daily treatment in patients with chronic asthma?
Answers are grounded in this paper and cite their sources.
Intermittent corticosteroid treatment in chronic asthma does not appear to increase mortality or peptic ulceration compared to continuous daily treatment at a comparable annual dose.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Merrett et al. (1966) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: